Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma

J Clin Oncol. 2013 Apr 20;31(12):e215-7. doi: 10.1200/JCO.2012.45.7028. Epub 2013 Mar 18.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Facial Paralysis / chemically induced*
  • Facial Paralysis / drug therapy
  • Humans
  • Indoles / adverse effects*
  • Male
  • Melanoma / complications
  • Melanoma / drug therapy*
  • Middle Aged
  • Prednisone / therapeutic use*
  • Sulfonamides / adverse effects*
  • Treatment Outcome
  • Vemurafenib

Substances

  • Antineoplastic Agents, Hormonal
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Prednisone